Lyumjev

Product manufactured by Eli Lilly And Company

Application Nr Approved Date Route Status External Links
BLA761109 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lyumjev™ Is Indicated To Improve Glycemic Control In Adults With Diabetes Mellitus. Lyumjev™ Is A Rapid-Acting Human Insulin Analog Indicated To Improve Glycemic Control In Adults With Diabetes Mellitus. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Insulin Lispro

Comments